Amneal Pharmaceuticals, Inc. - COM STK CL A (AMRX)

Q1 2020 13F Holders as of 3/31/2020

Type / Class
Equity / COM STK CL A
Number of holders
117
Total Shares
98.3M
Shares change
-2.86M
Total reported value, excl. options
$342M
Value change
-$17.3M
Put/Call ratio
2.87
Number of buys
61
Number of sells
-62
Price
$3.48
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.